share_log
下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>

Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%

空头股数在BetterLife制药公司(场外交易代码:BETRF)下跌20.5%

Defense World ·  08/04 16:11

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is currently 1.2 days.

BetterLife Pharma Price Performance

OTCMKTS BETRF opened at $0.11 on Thursday. The company has a market cap of $5.52 million, a P/E ratio of -0.89 and a beta of 2.90. The stock has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.11. BetterLife Pharma has a 1-year low of $0.05 and a 1-year high of $0.30.

Get BetterLife Pharma alerts:

BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last posted its quarterly earnings data on Tuesday, June 28th. The company reported ($0.03) EPS for the quarter.

About BetterLife Pharma

(Get Rating)

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.

Further Reading

  • Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
  • There Are Different Types of Stock To Invest In
  • Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
  • PayPal Continues To Struggle As Competition Increases
  • Is Starbucks Shooting For The Moon?
  • Two High-Yield Deep-Values You Shouldn't Ignore

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

风险提示:以上内容仅作为作者或者嘉宾的观点,不代表富途的任何立场,不构成与富途相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性,对此富途不做任何保证和承诺。